Dear Doctor - Participate in the Survey on hepatitis of unknown etiology " A recent survey of hepatitis cases of unknown etiology in children found that the vast majority of cases were in infants under the age of 6 months. The most common symptoms reported were fever, diarrhea, and vomiting. However, a small number of children also had jaundice and liver enzymes that were elevated. The most common tests used to diagnose hepatitis are the alanine aminotransferase (ALT) test and the aspartate aminotransferase (AST) test. These tests can be used to identify liver damage and determine the cause of the hepatitis. In some cases, additional testing, such as a viral load test or a liver biopsy, may be needed to confirm the diagnosis. Treatment for hepatitis usually involves supportive care, such as rest and fluids, and may also include medications to reduce liver inflammation or suppress the immune system. Participate in Surveys "
1.
Retired Olympic athletes at greater risk of skin cancer and osteoarthritis, research reveals
2.
Three Cycles of Chemo Noninferior to Six for Rare Childhood Eye Cancer
3.
Celebrity Cancers Stoking Fear? Cisplatin Shortage Ends; Setback for Anti-TIGIT
4.
Year in Review: Non-Small Cell Lung Cancer
5.
Electronic Sepsis Alerts; Reducing Plaques in Coronary Arteries
1.
What Is Carboxyhemoglobin And How Can It Affect Your Health?
2.
Introducing the Corrected Calcium Calculator: A Revolutionary Tool in Medical Assessment
3.
Integrating Immunotherapy and Staging Guidelines in Lung Cancer Treatment
4.
The Technological Revolution in Precision Oncology and Tumor Microenvironment Therapy
5.
The Importance of Having a Quick and Effective Heparin Antidote
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Navigating the Complexities of Ph Negative ALL - Part XVI
3.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation